{"id":"https://openalex.org/W2014504205","doi":"https://doi.org/10.4155/bio.11.24","title":"Recommendations and Requirements for The Design of Bioanalytical Testing Used in Comparability Studies for Biosimilar Drug Development","display_name":"Recommendations and Requirements for The Design of Bioanalytical Testing Used in Comparability Studies for Biosimilar Drug Development","publication_year":2011,"publication_date":"2011-03-01","ids":{"openalex":"https://openalex.org/W2014504205","doi":"https://doi.org/10.4155/bio.11.24","mag":"2014504205","pmid":"https://pubmed.ncbi.nlm.nih.gov/21388266"},"language":"en","primary_location":{"id":"doi:10.4155/bio.11.24","doi":"https://doi.org/10.4155/bio.11.24","is_oa":false,"landing_page_url":"https://doi.org/10.4155/bio.11.24","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Xiao-Yan Cai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiao-Yan Cai","raw_affiliation_strings":["Department of Biologics Bioanalytical, Merck, 1011 Morris Avenue, Building U13-1, Union, NJ07083, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biologics Bioanalytical, Merck, 1011 Morris Avenue, Building U13-1, Union, NJ07083, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087919454","display_name":"Dominique Gouty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominique Gouty","raw_affiliation_strings":["Intertek USA dba Alta Analytical Laboratory, 3985 Sorrento Valley Blvd. Suite C, San Diego, CA92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intertek USA dba Alta Analytical Laboratory, 3985 Sorrento Valley Blvd. Suite C, San Diego, CA92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083450118","display_name":"Sharon Baughman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088114","display_name":"Intertek (United States)","ror":"https://ror.org/007whsh62","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088114","https://openalex.org/I4210140224"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Baughman","raw_affiliation_strings":["Clinical and Preclinical Pharmacokinetics, Intertek Pharmaceutical Services, 6170 Cornerstone Court East, Suite 230, San Diego, CA92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical and Preclinical Pharmacokinetics, Intertek Pharmaceutical Services, 6170 Cornerstone Court East, Suite 230, San Diego, CA92121, USA","institution_ids":["https://openalex.org/I4210088114"]}]},{"author_position":"middle","author":{"id":null,"display_name":"MS Ramakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143327","display_name":"Biocon (India)","ror":"https://ror.org/047kynf18","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210143327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"MS Ramakrishnan","raw_affiliation_strings":["Research and Development, Biocon Ltd, 20th KM Hosur Road, Electronics City, Bangalore560 100, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Biocon Ltd, 20th KM Hosur Road, Electronics City, Bangalore560 100, India","institution_ids":["https://openalex.org/I4210143327"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110259604","display_name":"Constance Cullen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constance Cullen","raw_affiliation_strings":["Department of Biologics Bioanalytical, Merck, 1011 Morris Avenue, Building U13-1, Union, NJ07083, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biologics Bioanalytical, Merck, 1011 Morris Avenue, Building U13-1, Union, NJ07083, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3155,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.78024992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"3","issue":"5","first_page":"535","last_page":"540"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9950000047683716},{"id":"https://openalex.org/keywords/comparability-studies","display_name":"comparability studies","score":0.7630000114440918},{"id":"https://openalex.org/keywords/bioanalytical-method-development","display_name":"bioanalytical method development","score":0.8569999933242798},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.7250000238418579},{"id":"https://openalex.org/keywords/immunogenicity-assays","display_name":"immunogenicity assays","score":0.9850000143051147},{"id":"https://openalex.org/keywords/reference-products","display_name":"reference products","score":0.46299999952316284},{"id":"https://openalex.org/keywords/biological-products","display_name":"biological products","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.958928108215332},{"id":"https://openalex.org/C197947376","wikidata":"https://www.wikidata.org/wiki/Q5155608","display_name":"Comparability","level":2,"score":0.8926045894622803},{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.7973858118057251},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5397035479545593},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42704877257347107},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.39615076780319214},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3761852979660034},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.3553194999694824},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3368868827819824},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3367254137992859},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2840299606323242},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24539107084274292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22602611780166626},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.18932238221168518},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.17353424429893494},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.14940214157104492},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09763479232788086},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.09052780270576477},{"id":"https://openalex.org/C114614502","wikidata":"https://www.wikidata.org/wiki/Q76592","display_name":"Combinatorics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4155/bio.11.24","doi":"https://doi.org/10.4155/bio.11.24","is_oa":false,"landing_page_url":"https://doi.org/10.4155/bio.11.24","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},{"id":"pmid:21388266","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21388266","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1967295501","https://openalex.org/W2046877602","https://openalex.org/W2066129490","https://openalex.org/W2069260705","https://openalex.org/W2069506532","https://openalex.org/W2132071446","https://openalex.org/W2138572955","https://openalex.org/W2144422333","https://openalex.org/W2414855635","https://openalex.org/W2492928450","https://openalex.org/W3006182500"],"related_works":["https://openalex.org/W2604027897","https://openalex.org/W2100300980","https://openalex.org/W2071998886","https://openalex.org/W7222950050","https://openalex.org/W3136366698","https://openalex.org/W2038607314","https://openalex.org/W2016067508","https://openalex.org/W2524390309","https://openalex.org/W2315845508","https://openalex.org/W3130961965"],"abstract_inverted_index":{"With":[0],"the":[1,13,15,27,34,65,75,95,98,110],"imminent":[2],"expiry":[3],"of":[4,9,17,38,64,88],"patents":[5],"on":[6,12,33],"a":[7,47],"number":[8],"biological":[10,39],"products":[11,40,67],"market,":[14],"development":[16,99],"biosimilars":[18],"(or":[19,71],"'follow-on":[20],"biologics')":[21],"creates":[22],"an":[23],"increasing":[24],"opportunity":[25],"in":[26],"biotechnology":[28],"industry.":[29],"Although":[30],"general":[31],"guidelines":[32],"quality":[35],"and":[36,83,100,105],"safety":[37],"also":[41],"apply":[42],"to":[43,49,61,68,79,108],"biosimilars,":[44],"there":[45],"is":[46,59,87],"need":[48],"address":[50],"specific":[51],"requirements":[52,96],"for":[53,97,102],"developing":[54,74],"biosimilar":[55,66,111],"drugs.":[56],"Since":[57],"it":[58],"critical":[60],"show":[62],"comparability":[63,85],"their":[69],"reference":[70],"innovator)":[72],"products,":[73],"appropriate":[76],"bioanalytical":[77],"methods":[78],"support":[80,109],"such":[81],"preclinical":[82],"clinical":[84],"studies":[86],"great":[89],"importance.":[90],"The":[91],"present":[92],"work":[93],"recommends":[94],"validation":[101],"both":[103],"pharmacokinetic":[104],"immunogenicity":[106],"assays":[107],"drug":[112],"development.":[113]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}